Ear infections often develop due to allergies or an upper respiratory infection. Otitis media (a ... especially if they contain an anesthetic (numbing agent) like lidocaine hydrochloride.

Two biosimilars developed under the Teva - Alvotech partnership have been granted FDA approval with interchangeability, including SELARSDI. In February 2024, the FDA approved SIMLANDI ® ...

After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody ...

Hypochlorous acid is safe enough to spray in your eyes yet more effective than bleach. Why isn’t it everywhere?

Hopwood [8] reported that among 23 pregnant patients who developed pneumonia, all had prior upper respiratory tract infection and 20 ... C drug -- but this agent has also not been adequately ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting, taking place May 3-6 in San Diego, California. The oral and poster ...

AT-II-receptor antagonists were developed as agents that would more completely ... receptor antagonists dizziness, headache, upper-respiratory- tract infection, cough, and gastrointestinal ...